Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087995 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm
A NA study of Diabetes Mellitus, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 3
- Study locations
NCT02087995: Completed NA study of Diabetes Mellitus, sponsored by DexCom.
NCT02087995 is a NA study of Diabetes Mellitus that has completed, run by DexCom. The registered enrollment target is 51 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02087995, a NA study of Diabetes Mellitus, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 3
- Study locations
Study Summary
To establish the performance of the Dexcom G4 Platinum with a Modified Algorithm continuous monitoring system when compared to a laboratory reference measurement.
Primary Outcome
The percentage of CGM system values that are within 20% of the reference value for YSI glucose levels \> 80 mg/dL or within 20 mg/dL at the reference glucose levels \< 80 mg/dL.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitoring
Study Locations (3)
California
- John Muir Physician Network Clinical Research - Concord
- AMCR Institute - Escondido
- Diablo Clinical Research, Inc. - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT02087995 record still lists
NCT02087995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.
NCT02087995 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02087995 about?
NCT02087995 is a clinical study titled "Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm". To establish the performance of the Dexcom G4 Platinum with a Modified Algorithm continuous monitoring system when compared to a laboratory reference measurement.
What is the current status of trial NCT02087995?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-12. Estimated completion is 2014-03.
What conditions does trial NCT02087995 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT02087995?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT02087995?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087995 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02087995's enrollment target sits among peer trials
51 150th of 208 higher than 59 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia